Article
Targeting Glioblastoma Cell State Plasticity for Enhanced Therapeutic Efficacy
2025-09-12
Abstract excerpt
<h4>Summary</h4> Glioblastoma (GBM) is the most common and deadly primary brain cancer, with limited therapeutic options. Treatment failure has been associated with intratumoral heterogeneity and the acquisition of a pronounced mesenchymal-like (MES-L) phenotype after recurrence. Here, we have screened a panel of drugs with diverse mechanisms of action across two patient-derived glioblastoma stem cells (GSCs) to...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 1877d2c3-922e-54d2-952e-ddba39a43ebf
- DOI
- 10.1101/2025.09.08.674897
